BALYASNY ASSET MANAGEMENT L.P. 13D and 13G filings for Contineum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 06:02 am Sale | 2026-06-30 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | BALYASNY ASSET MANAGEMENT L.P. | 2,335,550 7.140% | -82,173 (-3.40%) | Filing |
| 2026-05-15 06:41 am Purchase | 2026-03-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | BALYASNY ASSET MANAGEMENT L.P. | 2,417,723 7.400% | 104,923 (+4.54%) | Filing |
| 2026-02-17 06:28 am Purchase | 2025-12-31 | 13G | CONTINEUM THERAPEUTICS INC CL CTNM | BALYASNY ASSET MANAGEMENT L.P. | 2,312,800 7.600% | 2,312,800 (New Position) | Filing |